Gerber Kawasaki Wealth & Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2
Closed -$2K 678
2021
Q3
$2K Sell
2
-16,096
-100% -$208K ﹤0.01% 890
2021
Q2
$207K Hold
16,098
0.02% 233
2021
Q1
$179K Sell
16,098
-4,874
-23% -$51.5K 0.02% 211
2020
Q4
$238K Buy
20,972
+6,392
+44% +$69.9K 0.03% 155
2020
Q3
$131K Sell
14,580
-1,500
-9% -$14.9K 0.03% 121
2020
Q2
$165K Hold
16,080
0.04% 127
2020
Q1
$162K Hold
16,080
0.05% 117
2019
Q4
$213K Sell
16,080
-4,380
-21% -$48.3K 0.05% 118
2019
Q3
$175K Buy
+20,460
New +$199K 0.05% 119
2018
Q2
Sell
-12,249
Closed -$158K 109
2018
Q1
$158K Hold
12,249
0.05% 112
2017
Q4
$153K Hold
12,249
0.05% 108
2017
Q3
$170K Buy
+12,249
New +$169K 0.06% 103
2017
Q2
Sell
-12,010
Closed -$165K 124
2017
Q1
$165K Sell
12,010
-3,821
-24% -$52.2K 0.07% 116
2016
Q4
$202K Buy
15,831
+2,089
+15% +$26.4K 0.11% 95
2016
Q3
$182K Hold
13,742
0.11% 92
2016
Q2
$150K Hold
13,742
0.09% 84
2016
Q1
$125K Hold
13,742
0.09% 76
2015
Q4
$133K Buy
+13,742
New +$133K 0.09% 78

Other funds holding IRWD

Gerber Kawasaki Wealth & Investment Management's IRWD Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2021, closing a stake of 2 shares — an estimated $2K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in IRWD in Q4 2015 and held it in 18 quarters. The position peaked at $238K in Q4 2020. 212 funds tracked by Wall St. Rank hold IRWD as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 2 Ironwood Pharmaceuticals shares in Q4 2021, an estimated $2K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 18 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Ironwood Pharmaceuticals position peaked at $238K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.